Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HETERO LABS LTD V

  • FDA Approval
  • July 29, 2025, 04:16 UTC
  • 54
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

CHARTWELL RX

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 70
  • 0 comments

FDA approve CEFPROZIL

Comment Full text

HOSPIRA

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 64
  • 0 comments

FDA approve DEXTROSE

Comment Full text

MSN

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 67
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text

RISING

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 75
  • 0 comments

FDA approve EXEMESTANE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 50
  • 0 comments

FDA approve EXEMESTANE

Comment Full text

RISING

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 56
  • 0 comments

FDA approve CEVIMELINE HYDROCHLORIDE

Comment Full text

QILU

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 62
  • 0 comments

FDA approve EXEMESTANE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 65
  • 0 comments

FDA approve PHENTERMINE HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • July 28, 2025, 08:53 UTC
  • 64
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text
  • Previous
  • 117
  • 118
  • 119
  • 120
  • 121
  • Next

Search

News categories

  • Technical Exchange News(11334)
  • Event(2785)
  • SEC News(205104)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(133829)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin